Tuesday, September 22, 2015

New Weapon in Push to Lower Biotech Drug Prices

The introduction of biosimilar drugs in the U.S. hands health-care payers a weapon against rising drug prices. In Europe, though, safety concerns and low awareness have slowed the adoption of biosimilars.

from WSJ.com: US Business http://ift.tt/1L4zhwo
via IFTTT

No comments:

Post a Comment